vimarsana.com

Page 5 - Nasdaq Dxcm News Today : Breaking News, Live Updates & Top Stories | Vimarsana

DexCom, Inc (NASDAQ:DXCM) Shares Sold by Handelsbanken Fonder AB

Handelsbanken Fonder AB lessened its stake in DexCom, Inc. (NASDAQ:DXCM – Free Report) by 5.3% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 439,991 shares of the medical device company’s stock after selling 24,615 shares during the quarter. Handelsbanken Fonder AB owned […]

Pinnacle Financial Partners Inc Sells 3,159 Shares of DexCom, Inc (NASDAQ:DXCM)

Pinnacle Financial Partners Inc trimmed its position in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) by 6.0% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 49,822 shares of the medical device company’s stock after selling 3,159 shares during […]

DexCom, Inc (NASDAQ:DXCM) Holdings Raised by ICICI Prudential Asset Management Co Ltd

ICICI Prudential Asset Management Co Ltd increased its position in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) by 8.7% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 3,750 shares of the medical device company’s stock after acquiring an […]

Insider Selling: DexCom, Inc (NASDAQ:DXCM) EVP Sells $579,180 00 in Stock

DexCom, Inc. (NASDAQ:DXCM – Get Free Report) EVP Sadie Stern sold 4,137 shares of the business’s stock in a transaction on Monday, March 25th. The stock was sold at an average price of $140.00, for a total value of $579,180.00. Following the completion of the transaction, the executive vice president now directly owns 76,304 shares […]

Inscription Capital LLC Makes New $248,000 Investment in DexCom, Inc (NASDAQ:DXCM)

Inscription Capital LLC purchased a new position in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 2,000 shares of the medical device company’s stock, valued at approximately $248,000. A number of other institutional […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.